Paula R. Pohlmann

4.5k total citations
100 papers, 2.3k citations indexed

About

Paula R. Pohlmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Paula R. Pohlmann has authored 100 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 31 papers in Cancer Research. Recurrent topics in Paula R. Pohlmann's work include HER2/EGFR in Cancer Research (31 papers), Advanced Breast Cancer Therapies (19 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Paula R. Pohlmann is often cited by papers focused on HER2/EGFR in Cancer Research (31 papers), Advanced Breast Cancer Therapies (19 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Paula R. Pohlmann collaborates with scholars based in United States, Brazil and Japan. Paula R. Pohlmann's co-authors include Ingrid A. Mayer, Ray Mernaugh, Daniela Dornelles Rosa, Erika Hamilton, John D. Powderly, Roel Funke, Maria I. Edelweiss, Aírton Tetelbom Stein, Sara M. Tolaney and Luciana Molinero and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Paula R. Pohlmann

95 papers receiving 2.2k citations

Peers

Countries citing papers authored by Paula R. Pohlmann

Since Specialization

Citations

This map shows the geographic impact of Paula R. Pohlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula R. Pohlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula R. Pohlmann more than expected).

Fields of papers citing papers by Paula R. Pohlmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula R. Pohlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula R. Pohlmann. The network helps show where Paula R. Pohlmann may publish in the future.

Co-authorship network of co-authors of Paula R. Pohlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Paula R. Pohlmann. A scholar is included among the top collaborators of Paula R. Pohlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula R. Pohlmann. Paula R. Pohlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach 2025 ·Clinical Cancer Research ·Taiwo Adesoye, Ecaterina E. Dumbrava, Kanwal Raghav, Ayşegül A. Şahin, Hui Chen, Sunyoung S. Lee, Milind Javle, Shubham Pant, Omar Alhalabi, Xiuning Le, Vicente Valero, Paula R. Pohlmann, Funda Meric‐Bernstam	0
2	Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody–Drug Conjugates (ADCs) 2024 ·Current Ophthalmology Reports ·(unknown), (unknown), Onur Çil, A.S. Verkman, Matilda F. Chan, Gerami D. Seitzman, Asim V. Farooq, Laura A. Huppert, Hope S. Rugo, Paula R. Pohlmann, Janice Lu, Laura J. Esserman, Neel D. Pasricha	7
3	A phase 1, first-in-human study of autologous monocytes engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2-overexpressing solid tumors. 2024 ·Journal of Clinical Oncology ·Yara Abdou, Paula R. Pohlmann, Richard T. Maziarz, Hemant S. Murthy, Yuan Yuan, Anuradha Krishnamurthy, (unknown), (unknown), Daniel J. Blumenthal, Linara Gabitova, (unknown), Kenneth W. Locke, (unknown), Michael Klichinsky, Daniel Cushing, Thomas Condamine, Davendra Sohal	4
4	Phase 2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 (trastuzumab imbotolimod) +/- pertuzumab (P) in patients (pts) with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab deruxtecan (T-DXd). 2024 ·Journal of Clinical Oncology ·Mark D. Pegram, Carmen Calfa, Christopher S. Chen, Alfonso Cortés, Arielle L. Heeke, Irene Kang, Barbara Pistilli, Paula R. Pohlmann, Hope S. Rugo, Cristina Saura, Cécile Vicier, Cecelia I. Pearson, Milan Mangeshkar, (unknown), Michael N. Alonso, Dawn Colburn, Edith A. Perez, Joshua Z. Drago	1
5	Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy 2024 ·Clinical Cancer Research ·Mark Jesus M. Magbanua, (unknown), Rosalyn W. Sayaman, Lamorna Brown Swigart, Gillian L. Hirst, Christina Yau, Denise M. Wolf, Wen Li, Amy L. Delson, Jane Perlmutter, Paula R. Pohlmann, W. Fraser Symmans, Douglas Yee, Nola M. Hylton, Laura J. Esserman, Angela DeMichele, Hope S. Rugo, Laura van ‘t Veer	2
6	Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and COP1 in Metastasis 2023 ·Cancers ·Jerry Xiao, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marc E. Lippman, Paula R. Pohlmann, Jay Zeck, John L. Marshall, Benjamin A. Weinberg, Aiwu Ruth He, Marcus Smith Noel, Richard Schlegel, Hani Goodarzi, Seema Agarwal	6
7	Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression 2023 ·Archives of Pathology & Laboratory Medicine ·Gary Tozbikian, Savitri Krishnamurthy, Marilyn M. Bui, Michael Feldman, David G. Hicks, Shabnam Jaffer, Thaer Khoury, (unknown), Hannah Y. Wen, Paula R. Pohlmann	4
8	885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab 2023 ·SHILAP Revista de lepidopterología ·(unknown), Filipa Lynce, Xue Geng, Edward T. Richardson, (unknown), Mei Wei, Julie Collins, Paula R. Pohlmann, Arielle L. Heeke, (unknown), (unknown), (unknown), Jane Staunton, Stuart J. Schnitt, Joan S. Brugge, Hongkun Wang, Claudine Isaacs, Geoffrey I. Shapiro, Jennifer L. Guerriero	1
9	132P Neoadjuvant zanidatamab for stage I node-negative HER2- positive breast cancer (BC) 2023 ·ESMO Open ·Vicente Valero, Jason Mouabbi, (unknown), (unknown), Rashmi K. Murthy, Xuelin Huang, Wei Qiao, Mihir R. Patel, Paula R. Pohlmann, Gaiane M. Rauch, Cristina M. Checka, Kelly K. Hunt, Debu Tripathy, Funda Meric‐Bernstam, (unknown)	3
10	HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane 2022 ·Breast Cancer Research and Treatment ·Paula R. Pohlmann, Deena Graham, (unknown), Yvonne Ottaviano, Mahsa Mohebtash, (unknown), (unknown), Filipa Lynce, Robert Warren, Asma Dilawari, Suman Rao, (unknown), (unknown), Ming Tan, Claudine Isaacs, Sandra M. Swain	4
11	Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function 2021 ·Breast Cancer Research and Treatment ·Katia Khoury, Filipa Lynce, Ana Barac, Xue Geng, Chau T. Dang, Anthony F. Yu, Karen L. Smith, Christopher Gallagher, Paula R. Pohlmann, Raquel Nunes, Pia Herbolsheimer, Robert Warren, Monvadi B. Srichai, Mark Hofmeyer, Federico M. Asch, Ming Tan, Claudine Isaacs, Sandra M. Swain	20
12	Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer 2021 ·Cancer ·Filipa Lynce, Matthew Blackburn, (unknown), Christopher Gallagher, Olwen Hahn, Maysa Abu‐Khalaf, Mahsa Mohebtash, (unknown), Paula R. Pohlmann, Asma Dilawari, Shruti Tiwari, (unknown), Robert Warren, Ming Tan, Ayesha N. Shajahan‐Haq, Claudine Isaacs	14
13	An evaluation of palbociclib as a breast cancer treatment option: a current update 2020 ·Expert Opinion on Pharmacotherapy ·(unknown), (unknown), Anna T. Riegel, Paula R. Pohlmann	4
14	Efficient Propagation of Circulating Tumor Cells: A First Step for Probing Tumor Metastasis 2020 ·Cancers ·Jerry Xiao, Joseph R. McGill, Kelly Stanton, (unknown), Sujata Maiti Choudhury, Richard Schlegel, Zuben E. Sauna, Paula R. Pohlmann, Seema Agarwal	17
15	Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer 2017 ·Cancer Research ·Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer, Luigi Formisano, Kyung‐min Lee, Katherine E. Hutchinson, Agnieszka K. Witkiewicz, Preston D. Moore, Mónica V. Estrada, Violeta Sánchez, Paula I. González-Ericsson, Melinda E. Sanders, Paula R. Pohlmann, Michael J. Pishvaian, (unknown), Teresa C. Dugger, Wenyi Wei, Erik S. Knudsen, Carlos L. Arteaga	171
16	Adjuvant platinum-based chemotherapy for early stage cervical cancer 2016 ·Cochrane Database of Systematic Reviews ·Frederico Soares Falcetta, Lídia RF Medeiros, Maria I. Edelweiss, Paula R. Pohlmann, Aírton Tetelbom Stein, Daniela Dornelles Rosa, Joanne Platt	53
17	A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort) 2009 ·BMC Public Health ·Maira Caleffi, Rodrigo Antonini Ribeiro, (unknown), Patrícia Ashton‐Prolla, (unknown), (unknown), (unknown), Juliana Giacomazzi, (unknown), Márcia Silveira Graudenz, Paula R. Pohlmann, Jefferson Gomes Fernandes, (unknown), Bernardete Weber	23
18	Accuracy of frozen-section analysis in the diagnosis of ovarian tumors: a systematic quantitative review 2005 ·International Journal of Gynecological Cancer ·Lídia Rosi Medeiros, Daniela Dornelles Rosa, Maria I. Edelweiss, Aírton Tetelbom Stein, Mary Clarisse Bozzetti, Alice Zelmanowicz, Paula R. Pohlmann, Luíse Meurer, (unknown)	74
19	CXCL8 secretion by dendritic cells predicts contact allergens from irritants 2005 ·Toxicology in Vitro ·M.J. Toebak, Paula R. Pohlmann, Shakun C. Sampat-Sardjoepersad, B. Mary E. von Blomberg, D. P. Bruynzeel, Rik J. Scheper, Thomas Rustemeyer, Susan Gibbs	84
20	[Smoking in Porto Alegre: prevalence and the role of health professionals in its prevention]. 1991 ·PubMed ·Paula R. Pohlmann, (unknown), (unknown), (unknown), Bruce Bartholow Duncan, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact